
May 6 (Reuters) - Hepion Pharmaceuticals Inc HEPA.O:
HEPION PHARMACEUTICALS - ON APRIL 30, ENTERED INTO BINDING LOI IN-LICENSES DIAGNOSTIC TESTS FROM NEW DAY DIAGNOSTICS - SEC FILING
HEPION PHARMACEUTICALS INC - TO PAY $525,000 CASH AND $200,000 IN STOCK TO NEW DAY - SEC FILING
HEPION PHARMACEUTICALS INC - AGREES TO PAY UP TO $17.15 MILLION UPON MILESTONE ACHIEVEMENT - SEC FILING
HEPION PHARMACEUTICALS INC - TO PAY ROYALTIES IN UPPER SINGLE TO LOW DOUBLE DIGITS BASED ON NET SALES- SEC FILING
Source text: [ID:n0001641172-25-008761]